COMPANY
Diazyme Laboratories
Timeline
- FDA FDA 510(k) clearance: Lipoprotein (a) Molarity Assay — K253069, Jun 16, 2026. Applicant at approval: Diazyme Laboratories, Inc. source ↗
- FDA FDA 510(k) clearance: Diazyme Immunoglobulin A Assay; Diazyme Immunoglobulin G Assay; Diazyme Immunoglobulin M Assay — K252336, Apr 24, 2026. Applicant at approval: Diazyme Laboratories, Inc. source ↗
- FDA FDA 510(k) clearance: Diazyme Human Kappa (k) Free Light Chain Assay; Diazyme Human Lambda (¿) Free Light Chain Assay — K253358, Dec 19, 2025. Applicant at approval: Diazyme Laboratories, Inc. source ↗
- FDA FDA 510(k) clearance: Diazyme Colorimetric Lithium Assay — K243462, Aug 1, 2025. Applicant at approval: Diazyme Laboratories, Inc. source ↗
FDA records (last 2 years)
- FDA 510(k) clearance: Lipoprotein (a) Molarity Assay — K253069, Jun 16, 2026. Applicant at approval: Diazyme Laboratories, Inc. source ↗
- FDA 510(k) clearance: Diazyme Immunoglobulin A Assay; Diazyme Immunoglobulin G Assay; Diazyme Immunoglobulin M Assay — K252336, Apr 24, 2026. Applicant at approval: Diazyme Laboratories, Inc. source ↗
- FDA 510(k) clearance: Diazyme Human Kappa (k) Free Light Chain Assay; Diazyme Human Lambda (¿) Free Light Chain Assay — K253358, Dec 19, 2025. Applicant at approval: Diazyme Laboratories, Inc. source ↗
- FDA 510(k) clearance: Diazyme Colorimetric Lithium Assay — K243462, Aug 1, 2025. Applicant at approval: Diazyme Laboratories, Inc. source ↗
Connect
See your connections at Diazyme Laboratories on LinkedIn (search by name, results not checked)